Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Myttle Mayuga"'
Autor:
Jarrod E. Dalton, Guilherme F. Attizzani, Myttle Mayuga, Sadeer G. Al-Kindi, Anthony E. DeCicco, Nicholas T. Funderburg, Sahil A. Parikh, Eugene H. Blackstone, Marco A. Costa, Daniel I. Simon, Chris T. Longenecker, Ahmad Alkhalil, Michael M. Lederman, David A. Zidar
Publikováno v:
Journal of Cardiovascular Medicine. 19:191-194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9db63e5857a9df42ae348bc72e775f
https://doi.org/10.2459/jcm.0000000000000624
https://doi.org/10.2459/jcm.0000000000000624
Autor:
Robyn Osborne, Samantha R. Stubblefield Park, Robert M. Califf, Jeffrey B. Washam, Michael M. Lederman, Cliburn Chan, Nicholas T. Funderburg, Masakazu Ishikawa, Adeyinka Owoyele, Carl E. Orringer, Mohamad Amer Alaiti, Steven M Juchnowski, Daniel I. Simon, David A. Zidar, Myttle Mayuga, Curtis Tatsuoka, Kent J. Weinhold, Marco A. Costa, Joseph C. Mudd, Joao Pedro Lopes, Sara D. Sparks, L. Kristin Newby
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 36(2)
Objective— Inflammation in response to oxidized lipoproteins is thought to play a key role in acute coronary syndromes (ACS), but the pattern of immune activation has not been fully characterized. We sought to perform detailed phenotypic and functi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660b6ea40854922e55e51abf242e0dc0
https://pubmed.ncbi.nlm.nih.gov/26663396
https://pubmed.ncbi.nlm.nih.gov/26663396
Autor:
Myttle Mayuga, Isidore Okere, Darwin Jeyaraj, Elad Asher, Daniel I. Simon, Tom Lassar, Martin Bradley, Ka Chun Alan Chan, Perry Anarado
Publikováno v:
Journal of the American College of Cardiology. 61(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d041b69b54502e8299d2c95c588c61a
Autor:
Walter Jeske, Meyer Michel Samama, Jeanine M. Walenga, Debra Hoppensteadt, Myttle Mayuga, Jawed Fareed
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 22(3)
Fondaparinux (Arixtra) is an antithrombin (AT)-dependent synthetic inhibitor of factor Xa (FXa). We undertook a study to determine the ramifications of varying levels of circulating AT on the pharmacologic activity of fondaparinux. AT-deficient human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77b9a3949a776396fda7e70ccd732ce
https://pubmed.ncbi.nlm.nih.gov/21297455
https://pubmed.ncbi.nlm.nih.gov/21297455
Autor:
Jeanine M. Walenga, Myttle Mayuga, Margaret Prechel, Sebastian Harder, Debra Hoppensteadt, Hikari Watanabe, Hans-Klaus Breddin, Masanori Osakabe, Amanda F. Drenth
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 14(3)
Treatment with the thrombin inhibitor argatroban is often followed by vitamin K-antagonist treatment. In this study, the behavior of coagulation factors measured under these treatment regimens is shown. Healthy subjects received infusions of 1.0, 2.0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::412ce08ab7f6e6c5fd7f45eb1c9604d0
https://pubmed.ncbi.nlm.nih.gov/18586683
https://pubmed.ncbi.nlm.nih.gov/18586683
Autor:
Perry Anarado, Daniel I. Simon, Ka Chun Alan Chan, Martin Bradley, Elad Asher, Darwin Jeyaraj, Myttle Mayuga, Tom Lassar, Isidore Okere
Publikováno v:
JACC: Cardiovascular Interventions. (2):S11-S12
To assess whether Accumetrix VerifyNow P2Y12 testing directed anti-platelet therapy after acute coronary syndromes (ACS) percutaneous coronary intervention (PCI) in a real world setting, could affect outcomes. Multiple trials suggest that high residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de95c25c6dcdcb0243e47856be262eb